Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

WeedMD & Shoppers Finish Cannabis Verification Pilot Phase 1

Stockhouse Editorial
2 Comments| August 14, 2019

{{labelSign}}  Favorites
{{errorMessage}}

Two big names in Canadian healthcare have just completed the first phase of a pilot project to authenticate all things medical cannabis.

WeedMD Inc. (TSX-V:WMD), in partnership with Shoppers Drug Mart (TSX: SC), has developed the pilot project using tech from TruTrace Technologies (CSE: TTT) and data from Deloitte Canada LLP. The pilot project is designed to enhance cannabis product testing and verification to confirm origin, authenticity and quality, of strains.


The project is built upon TruTrace’s StrainSecure system and is intended to help protect 40 of WeedMD’s unique registered strains and assist customers, including those for Shoppers Drug Mart, ensure authenticity with strains and products.

Phase 2 of the Pilot Project is scheduled to be complete by late November 2019.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company